Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study

Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-02262350
Contributor : Coralie Courtinard <>
Submitted on : Friday, August 2, 2019 - 12:32:58 PM
Last modification on : Saturday, August 3, 2019 - 1:37:47 AM

Links full text

Identifiers

Citation

S. Delaloge, D. Perol, C. Courtinard, E. Brain, B. Asselain, et al.. Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study. Annals of Oncology, Oxford University Press (OUP), 2016, 27 (9), pp.1725-1732. ⟨10.1093/annonc/mdw260⟩. ⟨hal-02262350⟩

Share

Metrics

Record views

12